Reactive astrocyte nomenclature, definitions, and future directions. He is a co-founder of Oscine Therapeutics, and his work is supported by NIH/NINDS, the Adelson Medical Research Foundation, the Mathers Charitable Foundation, the Novo Nordisk Foundation, and the Lundbeck Foundation. He serves on standing committees of the NIH, and has served as a voting member of the FDA Cellular, Tissue and Gene Therapy Advisory Committee. Goldman is a recipient of the Novo Nordisk Foundation Laureate Award, the Jacob Javits Neuroscience Investigator Award of the NIH, and has been elected to Academia Europaea, the Association of American Physicians, the American Society for Clinical Investigation, and the American Neurological Association, and he is a fellow of the American Academy of Neurology.

Visit our website to book an appointment online: Dr. He has published over 250 papers, over 100 as first or senior author, and holds over 30 patents in his field. Trusted Family Medicine / Anti-Aging Medicine & Clinical Research serving Charlotte, NC. He also has a strong interest in the conversion of resident cells into brain cancers, and is board certified in neuro-oncology. Goldman is interested in cell genesis and regeneration in the adult brain, with a focus on the use of stem and progenitor cells in both modeling and treating demyelinating and neurodegenerative diseases, including targets as diverse as progressive multiple sclerosis, the leukodystrophies, Huntington Disease and schizophrenia. Goldman remains active clinically, with subspecialty interests in myelin disease and neuro-oncology, and additional research interests in stem cell-based treatment of neurological disease. Goldman moved to Rochester as the Dean Zutes Chair in Biology of the Aging Brain, and as Chief of the Neurology department's Division of Cell and Gene Therapy he subsequently served as the founding director for Rochester's neuro-oncology training program, and served as Chairman of the Department (2008-12). Goldman interned in Medicine and did his residency in Neurology at both New York Hospital-Cornell and the Memorial Sloan-Kettering Cancer Center, before joining the Cornell faculty. A summa cum laude graduate of the University of Pennsylvania, he obtained his PhD with Fernando Nottebohm at the Rockefeller University in 1983, and his MD from Cornell in 1984.

Goldman moved to Rochester in 2003 from the Weill Medical College of Cornell University, where he was the Nathan Cummings Professor of Neurology, and Attending Neurologist at New York Presbyterian Hospital. He also serves as Senior Vice President and Head of CNS Therapy at Sana Biotechnology, in Cambridge, Massachusetts. He has a concurrent appointment as Professor of Neuroscience at the University of Copenhagen in Denmark, and as co-director of its sister Center for Translational Neuromedicine. Goldman is the URMC Distinguished Professor of Neuroscience and Neurology, and co-Director of Rochester's Center for Translational Neuromedicine.

Steven schwartz md